891
Views
0
CrossRef citations to date
0
Altmetric
Influenza

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults

ORCID Icon, , , , , , , , , , , , , & ORCID Icon show all
Article: 2236537 | Received 18 May 2023, Accepted 11 Jul 2023, Published online: 02 Aug 2023

References

  • Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–10. doi:10.1016/S0140-6736(17)33293-2.
  • Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9(10):601–10. doi:10.1016/S1473-3099(09)70233-6.
  • Canada Ministry of Health. 2022/2023 Universal Influenza Immunization Program (UIIP) [Internet]. 2022 [accessed 2023 Feb 27]. https://www.health.gov.on.ca/en/pro/programs/publichealth/flu/uiip/ .
  • CDC. Summary: ‘prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2022-23’ [Internet]. 2022 [accessed 2023 Feb 27]. https://www.cdc.gov/flu/professionals/acip/summary/summary-recommendations.htm .
  • WHO. WHO regional office for Europe recommendations on influenza vaccination for the 2021/2022 season during the ongoing COVID-19 pandemic [Internet]. 2021 [accessed 2023 Feb 27]. https://apps.who.int/iris/bitstream/handle/10665/347890/WHO-EURO-2021-3920-43679-61434-eng.pdf?sequence=1&isAllowed=y .
  • ECDC. Seasonal influenza vaccination strategies [Internet]. 2023 [accessed 2023 Feb 27]. https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/vaccination-strategies .
  • Ministerio de Sanidad. Recomendaciones de vacunación frente a la gripe Temporada 2020-2021 [Internet]. 2020 [accessed 2022 July 6]. https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/Recomendaciones_vacunacion_gripe.pdf .
  • Verelst F, Beutels P, Hens N, Willem L. Workplace influenza vaccination to reduce employee absenteeism: an economic analysis from the employers’ perspective. Vaccine. 2021;39(14):2005–15. doi:10.1016/j.vaccine.2021.02.020.
  • WHO. Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season [Internet]. 2021 [accessed 2023 Feb 16]. https://cdn.who.int/media/docs/default-source/influenza/who-influenza-recommendations/vcm-northern-hemisphere-recommendation-2021-2022/202102_recommendation.pdf?sfvrsn=2af603d8_12&download=true .
  • WHO Global Influenza. Surveillance network. Manual for the laboratory diagnosis and virological surveillance of influenza [Internet]. 2011 [accessed 2022 Feb 14]. https://apps.who.int/iris/handle/10665/44518 .
  • Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E. Overview of serological techniques for influenza vaccine evaluation: past, present and future. Vaccines (Basel). 2014;2(4):707–34. doi:10.3390/vaccines2040707.
  • EMA. Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96) [Internet]. 1997 [accessed 2023 Feb 20]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf .
  • Aguolu OG, Willebrand K, Elharake JA, Qureshi HM, Kiti MC, Liu CY, Restrepo Mesa A, Nelson K, Jenness S, Melegaro A, et al. Factors influencing the decision to receive seasonal influenza vaccination among US corporate non-healthcare workers. Hum Vaccin Immunother. 2022;18(6):2122379. doi:10.1080/21645515.2022.2122379.
  • Díez-Domingo J, Redondo Margüello E, Ortiz de Lejarazu Leonardo R, Gil de Miguel Á, Guillén Ortega JM, Rincón Mora J, Martinón-Torres F. A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018–19 season: the Gripómetro. BMC Public Health. 2022;22(1):825. doi:10.1186/s12889-022-13193-x.
  • Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol. 1988;127(2):353–64. doi:10.1093/oxfordjournals.aje.a114809.
  • Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza at Christ´s hospital. Lancet. 1979;313(8106):33–5. doi:10.1016/S0140-6736(79)90468-9.
  • Hoskins TW, Davies JR, Smith AJ, Allchin A, Miller CL, Pollock TM. Influenza at Christ´s hospital: March, 1974. Lancet. 1976;307(7951):105–8. doi:10.1016/S0140-6736(76)93151-2.
  • Beyer WEP, de Bruijn IA, Palache AM, Westendorp RGJ, Osterhaus ADME. The plea against annual influenza vaccination? ‘The Hoskins’ paradox’ revisited. Vaccine. 1998;16(20):1929–32. doi:10.1016/S0264-410X(98)00123-6.
  • Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997;15(10):1114–22. doi:10.1016/S0264-410X(97)00003-0.
  • Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, McCauley JW, Russell CA, Smith DJ, Rambaut A, et al. Integrating influenza antigenic dynamics with molecular evolution. Elife. 2014;3:e01914. doi:10.7554/eLife.01914.
  • Janssens Y, Joye J, Waerlop G, Clement F, Leroux-Roels G, Leroux-Roels I. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Front Immunol. 2022;13:959379. doi:10.3389/fimmu.2022.959379.
  • Wild K, Smits M, Killmer S, Strohmeier S, Neumann-Haefelin C, Bengsch B, Krammer F, Schwemmle M, Hofmann M, Thimme R, et al. Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination. Nat Commun. 2021;12(1):6720. doi:10.1038/s41467-021-27064-3.
  • Worlwide Influenza Centre. The Francis Crick Institute. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the southern hemisphere 2022 [Internet]. 2021 [accessed 2023 June 22]. https://www.crick.ac.uk/sites/default/files/2021-10/SH%20Sept%202021%20WIC%20web%20report%20v2.pdf .
  • Sullivan SG, Kelly H. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clin Infect Dis. 2013;57(3):474–6. doi:10.1093/cid/cit255.
  • Leung VKY, Fox A, Carolan LA, Aban M, Laurie KL, Druce J, Deng Y-M, Slavin MA, Marshall C, Sullivan SG, et al. Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016. Vaccine. 2021;39(24):3270–8. doi:10.1016/j.vaccine.2021.04.036.
  • Thompson MG, Naleway A, Fry AM, Ball S, Spencer SM, Reynolds S, Bozeman S, Levine M, Katz JM, Gaglani M. Effects of repeated annual inactivated influenza vaccination among healthcare personnel on serum hemagglutinin inhibition antibody response to A/Perth/16/2009 (H3N2)-like virus during 2010–11. Vaccine. 2016;34(7):981–8. doi:10.1016/j.vaccine.2015.10.119.
  • Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, Serres GD. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 2017;16(7):723–36. doi:10.1080/14760584.2017.1334554.
  • Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, Warshawsky BF. The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis. BMC Med. 2019;17(1):9. doi:10.1186/s12916-018-1239-8.
  • Jones-Gray E, Robinson EJ, Kucharski AJ, Fox A, Sullivan SG. Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis. Lancet Respir Med. 2023;11(1):27–44. doi:10.1016/S2213-2600(22)00266-1.
  • Ferro A, Bordin P, Benacchio L, Fornasiero F, Bressan V, Tralli V, Moretti F, Majori S. Influenza vaccination and absenteeism among healthy working adults: a cost-benefit analysis. Ann Ig. 2020;32(3):234–44. doi:10.7416/ai.2020.2346.
  • Ferdinands JM, Gaglani M, Martin ET, Monto AS, Middleton D, Silveira F, Talbot, HK, Zimmerman, R, Patel, M. Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015–2016 to 2018–2019, United States hospitalized adult influenza vaccine effectiveness network. Clin Infect Dis. 2021;73(4):726–9. doi:10.1093/cid/ciab045.
  • Hu W, Sjoberg PA, Fries AC, DeMarcus LS, Robbins AS. Waning vaccine protection against influenza among department of defense adult beneficiaries in the United States, 2016-2017 through 2019-2020 influenza seasons. Vaccines (Basel). 2022;10(6):888. doi:10.3390/vaccines10060888.
  • Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211(2):144–56. doi:10.1002/path.2104.
  • Lawton G. You’re only as young as your immune system. New Sci. 2020;245(3275):44–8. doi:10.1016/S0262-4079(20)30646-1.
  • Zhang A, Stacey HD, Mullarkey CE, Miller MS. Original antigenic sin: how first exposure shapes lifelong anti–influenza virus immune responses. J Immunol. 2019;202(2):335–40. doi:10.4049/jimmunol.1801149.
  • Haaheim LR. Original antigenic sin. A confounding issue? Dev Biol (Basel). 2003;115:49–53.
  • Monto AS, Malosh RE, Petrie JG, Martin ET. The doctrine of original antigenic sin: separating good from evil. J Infect Dis. 2017;215(12):1782–8. doi:10.1093/infdis/jix173.
  • Ye F, Chen XJ, Guan WD, Pan SH, Yang ZF, Chen RC. Analysis of influenza B virus lineages and the HA1 domain of its hemagglutinin gene in Guangzhou, southern China, during 2016. Virol J. 2018;15(1):175. doi:10.1186/s12985-018-1085-5.
  • Chen JM, Guo YJ, Wu KY, Guo JF, Wang M, Dong J, Zhang Y, Li Z, Shu Y-L. Exploration of the emergence of the Victoria lineage of influenza B virus. Arch Virol. 2007;152(2):415–22. doi:10.1007/s00705-006-0852-6.
  • Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B. 2001;356(1416):1861–70. doi:10.1098/rstb.2001.0999.
  • Xu C, Chan KH, Tsang TK, Fang VJ, Fung ROP, Ip DKM, Cauchemez S, Leung GM, Peiris JM, Cowling BJ. Comparative epidemiology of influenza B Yamagata- and Victoria-lineage viruses in households. Am J Epidemiol. 2015;182(8):705–13. doi:10.1093/aje/kwv110.
  • Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR. Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 2015;101(21):1738–47. doi:10.1136/heartjnl-2015-307691.
  • García-Lledó A, Rodríguez-Martín S, Tobías A, García-de-Santiago E, Ordobás-Gavín M, Ansede-Cascudo JC, Alonso‐Martín J, De Abajo FJ. Relationship between influenza, temperature, and type 1 myocardial infarction: an ecological time-series study. J Am Heart Assoc. 2021;10(8):e019608. doi:10.1161/JAHA.120.019608.
  • Blackburn R, Zhao H, Pebody R, Hayward A, Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015. Clin Infect Dis. 2018;67(1):8–17. doi:10.1093/cid/cix1144.
  • Boehme AK, Luna J, Kulick ER, Kamel H, Elkind MSV. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018;5(4):456–63. doi:10.1002/acn3.545.
  • de Abajo FJ, Rodríguez-Martín S, Barreira D, Rodríguez-Miguel A, Fernández-Antón E, Gil M, García-Lledó A. Influenza vaccine and risk of acute myocardial infarction in a population-based case–control study. Heart. 2022 de junio de 10;108(13):1039–45. doi:10.1136/heartjnl-2021-319754.
  • Fröbert O, Götberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, Oldroyd KG, Motovska Z, Erglis A, Moer R, et al. Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial. Circulation. 2021;144(18):1476–84. doi:10.1161/CIRCULATIONAHA.121.057042.
  • Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, Seet BT, Weinke T, Yu H. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39:A6–14. doi:10.1016/j.vaccine.2020.09.048.
  • Modin D, Claggett B, Køber L, Schou M, Jensen JUS, Solomon SD, Vardeny O, Knop FK, Nielsen SD, Fralick M, et al. Influenza vaccination is associated with reduced cardiovascular mortality in adults with diabetes: a nationwide cohort study. Diabetes Care. 2020;43(9):2226–33. doi:10.2337/dc20-0229.